TNF and Schnyder corneal dystrophy: This study also found that the IL-1b receptor antagonist anakinra was less effective than TNF blockers in reducing monocyte activation and inflammation, suggesting that monocyte-derived TNF-a may be the sentinel cytokine in the SCD inflammatory axis [42].